A PubMed Central-hosted review of peptide-based obesity treatments describes "nausea, vomiting and loss of appetite" as common effects of the GLP-1 drug class (pmc.ncbi.nlm.nih.gov)
Open 5 , e221169e221169 (2022)
The only organization she could find already doing something close to what I had described was Andel and she was actively trying to get a hold of them when, I kid you not when I say that literally two days later Andel emailed me directly for a guest spot on the podcast
Look Great, Feel Confident
Use protein powder if solid food is hard
If youre interested in a structured low-dose approach, Nooms Microdose GLP-1 Rx Program is designed specifically for thatwith medication included, a dedicated titration protocol, and built-in support tools